Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Antipsychotic medication adherence in schizophrenia.

Byerly MJ, Nakonezny PA, Lescouflair E.

Psychiatr Clin North Am. 2007 Sep;30(3):437-52. Review.

PMID:
17720031
2.

Interventions to improve antipsychotic medication adherence: review of recent literature.

Dolder CR, Lacro JP, Leckband S, Jeste DV.

J Clin Psychopharmacol. 2003 Aug;23(4):389-99. Review.

PMID:
12920416
3.

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV.

J Clin Psychiatry. 2002 Oct;63(10):892-909. Review.

PMID:
12416599
4.
5.

[Therapeutic alliance, a stake in schizophrenia].

Charpentier A, Goudemand M, Thomas P.

Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Review. French.

PMID:
19250998
6.

Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.

Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP.

J Psychiatr Pract. 2010 Jan;16(1):34-45. doi: 10.1097/01.pra.0000367776.96012.ca. Review.

PMID:
20098229
7.

Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.

Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L.

Eur Psychiatry. 2012 Jan;27(1):9-18. doi: 10.1016/j.eurpsy.2011.02.005. Review.

8.

[Adherence to antipsychotic medication in schizophrenia patients].

Baloush-Kleinman V, Poyurovsky M, Koren D, Schneidman M, Weizman A, Shnitt D.

Harefuah. 2002 Dec;141(12):1042-9, 1090. Review. Hebrew.

PMID:
12534202
9.

Improving adherence to antipsychotic pharmacotherapy.

Masand PS, Narasimhan M.

Curr Clin Pharmacol. 2006 Jan;1(1):47-56. Review.

PMID:
18666377
10.

[Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].

Puschner B, Born A, Giessler A, Helm H, Becker T, Angermeyer MC.

Psychiatr Prax. 2005 Mar;32(2):62-7. Review. German.

PMID:
15712037
11.

Lack of insight in schizophrenia: impact on treatment adherence.

Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC.

CNS Drugs. 2007;21(2):129-41. Review.

PMID:
17284095
12.

Tactics and technologies to manage nonadherence in patients with schizophrenia.

Glazer WM, Byerly MJ.

Curr Psychiatry Rep. 2008 Aug;10(4):359-69. Review.

PMID:
18627676
13.
14.
15.

Determinants of medication compliance in schizophrenia: empirical and clinical findings.

Fenton WS, Blyler CR, Heinssen RK.

Schizophr Bull. 1997;23(4):637-51. Review.

16.

Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments, and prospects.

Young JL, Spitz RT, Hillbrand M, Daneri G.

J Am Acad Psychiatry Law. 1999;27(3):426-44. Review.

PMID:
10509942
17.

Treatment adherence and long-term outcomes.

Kane JM.

CNS Spectr. 2007 Oct;12(10 Suppl 17):21-6. Review.

PMID:
17934386
18.

Does compliance therapy improve use of antipsychotic medication?

Ilott R.

Br J Community Nurs. 2005 Nov;10(11):514-9. Review.

PMID:
16301926
19.

Improving patient outcomes in schizophrenia: achieving remission.

Nasrallah HA, Lasser R.

J Psychopharmacol. 2006 Nov;20(6 Suppl):57-61. Review.

PMID:
17046987
20.

Sexual dysfunction in schizophrenia: focus on recent evidence.

Baggaley M.

Hum Psychopharmacol. 2008 Apr;23(3):201-9. doi: 10.1002/hup.924. Review.

PMID:
18338766
Items per page

Supplemental Content

Support Center